Appeal No. 95-1146 Application No. 07/913,126 teaches that curing may be accelerated, optionally, by the inclusion of p-toluene-sulfonic acid. Most of Cady's examples utilize p-toluene-sulfonic acid, not an amine, and Cady discloses a variety of ways of obtaining hydroxy functionality other than the inclusion of an amine (column 2, lines 41 et seq.). We also do not find that TABLE 4 of appellants' specification is evidence of nonobviousness, since the data is not germane to the claimed subject matter. The compositions set forth in TABLE 4 are solvent-borne compositions, whereas the claimed composition is in an aqueous medium. We will not sustain the obviousness-type double patenting rejection over U.S. Patent No. 4,778,869 because the claims of the patent are directed to a copolymer containing ether functionality, not the claimed hydroxy functionality. Also, the patented claims are directed to a polymer containing active hydrogen functionality provided by an amine, which is excluded by the appealed claims. In conclusion, based on the foregoing, the examiner's decision rejecting the appealed claims is reversed. REVERSED -7-Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007